Enhanced Genomics Limited
- Company number
- 12423696
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 24 Jan 2020
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- GMV Nominees Ltd (48052 companies)
Registered office
Previous names
- Enhanc3d Genomics Ltd (until 3 Sep 2025)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JONES, Hazel Joanne, Dr | Director | 7 May 2024 | 4 Feb 2025 |
| MAURICE, Catherine | Secretary | 1 Apr 2025 | 1 Jul 2026 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Mikhail Spivakov | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
24 Jan 2020 | 5 Aug 2020 |
| Dr Stefan Walter Schoenfelder | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
24 Jan 2020 | 5 Aug 2020 |
| Prof Peter John Fraser | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
24 Jan 2020 | 5 Aug 2020 |
| Prof Peter John Fraser | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
8 Dec 2020 | 1 Apr 2021 |
| Bioqube Factory Fund I Commv | Ownership Of Shares 25 To 50 Percent | 30 Mar 2021 | 2 Sep 2022 |
| Mnl (Parkwalk) Nominees Limited | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
26 Nov 2025 | |
| Bgf Investment Management Limited | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
28 Aug 2025 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2024 | £3,694,275 | £1,933,315 | 21 |
| 31 Dec 2023 | £7,120,276 | £6,479,614 | 12 |
| 31 Dec 2022 | £9,783,520 | £8,965,975 | 8 |
| 31 Dec 2021 | £965,058 | £855,508 | 7 |
Connections
Owned by
Enhanced Genomics Limited → BGF Investment Management Limited → BGF Group PLC → Barclays Funds Investments Limited → Barclays Equity Holdings Limited → Barclays Principal Investments Limited